Search

everythinglearnresearchcommunity

for

Search:↓

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

More precise, personalized therapies are needed for autoimmune diseases.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Adiponectin reduces hair pigmentation and affects hair growth signals.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

Melatonin promotes hair growth and quality by enhancing hair follicle development and reducing stress.

Vitamin D is needed for metformin to lower prolactin effectively.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

BMAL1 and Period1 genes can influence human hair growth.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Healthy mitochondria in skin cells are essential for proper hair growth and skin cell interaction in mice.

Hair follicles significantly enhance electroosmotic transport during iontophoresis.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

Melatonin helps reduce aging signs in human eyelid skin.

Innovative cosmetics could safely change hair color by targeting biological hair pigmentation processes.

Human skin can be reconnected to nerves using stem cells, which may help with skin health and healing.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

New methods to test hair growth treatments have been developed.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Blue light masks improved coat condition and energy in horses with PPID.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Hair graying may be caused by stem cell depletion from stress or melanocyte damage.

Taking biotin supplements can cause incorrect thyroid test results, leading to wrong diagnoses.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.